Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Porcupine Inhibition for Severe Sclerosteosis
2026-09-09
The reference study identifies PORCN inhibition with LGK974 as a pharmacological strategy for reducing excessive Wnt-driven bone formation in Sost-deficient mice. Its combination of osteoblast, osteoclast, gene-expression, microcomputed tomography, and mechanical-loading analyses provides a useful framework for evaluating treatments for severe sclerosteosis while highlighting sex-dependent responses and important translational limitations.
Better In Vitro Drug Response Metrics in Cancer
2026-09-09
Hannah R. Schwartz’s 2022 dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of an anticancer response. Its central methodological implication is that cancer research workflows should define, measure, and interpret proliferation arrest and cell killing separately rather than treating one viability value as a complete description of drug activity.
Anlotinib Hydrochloride in Translational Angiogenesis
2026-09-08
An evidence-led analysis of how Anlotinib hydrochloride connects multi-target kinase biology with practical angiogenesis workflows, comparative research strategy, and translational decision-making in cancer research.
Indometacin and COX-2 in Pancreatic Stellate Cells
2026-09-08
The reference study shows that indometacin suppresses human pancreatic stellate cell viability, migration, and activation while reducing COX-2 expression. Its main contribution is to position COX-2-dependent stromal remodeling as a pharmacologically tractable component of pancreatic ductal adenocarcinoma biology, while also defining practical readouts for cell-based validation.
Chenodeoxycholic Acid in FXR Renal Models
2026-09-07
Chenodeoxycholic Acid (CDCA) connects bile acid metabolism with FXR-driven transcriptional control in renal injury models. This guide translates the FXR–KLF11 finding into practical cell, reporter, ChIP, and troubleshooting workflows while keeping preclinical limitations explicit.
Ferrostatin-1 (Fer-1) in Ferroptosis Assays
2026-09-07
Ferrostatin-1 (Fer-1) provides a practical rescue control for testing iron-dependent lipid peroxidation across cell-injury models. This guide translates recent facial nerve repair research into reproducible assay setup, formulation comparisons, and troubleshooting decisions for cancer biology research and neurodegenerative disease models.
Firefly Luciferase mRNA for Translational Insight
2026-09-05
A mechanistic and strategic guide to using Firefly Luciferase mRNA (ARCA, 5-moUTP) as a reproducible reporter for gene expression assays, cell viability studies, delivery benchmarking, and in vivo imaging.
Neticonazole Hydrochloride: Evidence by Assay
2026-09-04
Neticonazole Hydrochloride is an imidazole antifungal with a clinically established topical role and a separate, preclinical oncology research profile. This article maps its evidence to diagnostic, antifungal, exosome, and apoptosis assays while clarifying translational limits.
Doxycycline in AAA Research: Assay Design Guide
2026-09-04
Doxycycline is more than a tetracycline antibiotic in abdominal aortic aneurysm research. This assay-focused guide explains how to separate antimicrobial, metalloproteinase, oxidative-stress, and delivery effects for more interpretable preclinical experiments.
Prochlorperazine: A Translational Melanoma Thesis
2026-09-03
Prochlorperazine is best understood not as a repurposing shortcut, but as a testable translational hypothesis linking dopamine D2 receptor antagonism, melanoma cell-state biology, and clinically familiar pharmacology. This article interprets the anchor study, proposes a disciplined validation strategy, and defines the boundaries between melanoma research, antiemetic therapy, and antiviral investigation.
GPNMB Model Predicts Immunotherapy Response in ESCC
2026-09-03
The reference study identifies circulating soluble GPNMB as a mechanistic and clinically useful marker of resistance to PD-1 blockade in esophageal squamous cell carcinoma. By integrating plasma GPNMB, CAF-Epi niche features, and clinicopathological variables, the authors develop a multimodal model that connects tumor–immune biology with response and survival prediction.
Staurosporine and the TBXA2R–ERM Metastasis Axis
2026-09-02
A translational perspective on how Staurosporine can interrogate kinase-dependent motility, invasion, apoptosis, and angiogenesis while clarifying the TBXA2R–ERM pathway identified in triple-negative breast cancer.
Pazopanib Hydrochloride: From Signal to Strategy
2026-09-02
Pazopanib Hydrochloride (GW786034) is more than a target list: it is a translational tool for studying how vascular and growth-factor signaling shape cancer phenotypes. This article connects its multi-kinase biology with better in vitro response measurements, practical assay design, clinical context, and a strategy for distinguishing proliferative arrest from true cell killing.
Syringin Natural Product: RCC Assay Workflows
2026-09-01
Syringin supports a practical RCC research workflow that connects viability, migration, apoptosis, and EGFR/PI3K/Akt pathway assays. Its strongest use-case is combination screening with sunitinib, where orthogonal readouts can distinguish genuine pathway modulation from nonspecific cytotoxicity.
Pifithrin-α: A Causal Tool for p53–Ferroptosis
2026-09-01
Pifithrin-α is a p53 inhibitor that helps distinguish p53-dependent apoptosis and ferroptosis from parallel stress responses. This article translates recent maternal deltamethrin neurotoxicity findings into a rigorous assay-design framework for mechanistic validation, controls, and interpretation.
8129 records 9/542 page Previous Next First page 上5页 678910 下5页 Last page